Search in:

Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 17

Submit an article Journal homepage

435

Views

CrossRef citations to date

Altmetric

Drug Evaluation

Quizartinib for the treatment of acute myeloid leukemia

Alejandro Garcia-Hortona Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, CANADA

https://orcid.org/0000-0003-0579-6709 View further author information

Karen Wl Yeea Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, CANADACorrespondence[email protected]
View further author information

Pages 2077-2090 | Received 24 Apr 2020, Accepted 22 Jul 2020, Published online: 09 Aug 2020

Cite this article
https://doi.org/10.1080/14656566.2020.1801637
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Jiaojiao Guo, Zhouling Xie, Wei Ruan, Qidong Tang, Dan Qiao & Wufu Zhu. (2023) Thiazole-based analogues as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and their SAR elucidation. European Journal of Medicinal Chemistry 259, pages 115689.
Crossref

André Soares Santos, Camila Oliveira Pereira & Daniela Almeida Freitas. (2022) FLT3 Inhibitors for the Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia: Systematic Review and Meta-analysis. SN Comprehensive Clinical Medicine 5:1.
Crossref

Ke-xin Li, Hui-yang Wu, Wan-ying Pan, Meng-qi Guo, De-zhi Qiu, Yan-jie He, Yu-hua Li, Dong-Hua Yang & Yu-xian Huang. (2022) A novel approach for relapsed/refractory FLT3mut+ acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib. Molecular Cancer 21:1.
Crossref

Quang Thinh Trac, Tingyou Zhou, Yudi Pawitan & Trung Nghia Vu. (2022) Discovery of druggable cancer-specific pathways with application in acute myeloid leukemia. GigaScience 11.
Crossref

Roberta Listro, Giacomo Rossino, Federica Piaggi, Falilat Folasade Sonekan, Daniela Rossi, Pasquale Linciano & Simona Collina. (2022) Urea-based anticancer agents. Exploring 100-years of research with an eye to the future. Frontiers in Chemistry 10.
Crossref

Fabiana Cacace, Rossella Iula, Danilo De Novellis, Valeria Caprioli, Maria Rosaria D’Amico, Giuseppina De Simone, Rosanna Cuccurullo, William G. Wierda, Kris Michael Mahadeo, Giuseppe Menna & Francesco Paolo Tambaro. (2022) High-Risk Acute Myeloid Leukemia: A Pediatric Prospective. Biomedicines 10:6, pages 1405.
Crossref

Özden Hatırnaz Ng & Ahmet Emre Eşkazan. (2022) Tackling TKI resistance in AML: A commentary on “Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.” by Yamatani et al.. Translational Oncology 19, pages 101394.
Crossref

Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak & Tomas Papajik. (2022) Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site. Biomedical Papers.
Crossref

Salihanur Darici, Manuela Zavatti, Luca Braglia, Benedetta Accordi, Valentina Serafin, Gillian A. Horne, Lucia Manzoli, Carla Palumbo, Xu Huang, Heather G. Jørgensen & Sandra Marmiroli. (2021) Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells. Advances in Biological Regulation 82, pages 100830.
Crossref

Xiaoyang Yang, Mengjie Wan, Feng Yu & Xiuji Wu. (2021) Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia. Cellular Signalling 87, pages 110144.
Crossref

Tristan E. Knight, Yubin Ge, Jeffrey W. Taub, Johann Hitzler & Joerg Krueger. (2021) When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3‐ITD AML. Pediatric Blood & Cancer 68:11.
Crossref

Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Emerson Lucena da Silva, Laudreísa da Costa Pantoja, Rodrigo Monteiro Ribeiro, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro, Rommel Mário Rodriguez Burbano, André Salim Khayat & Caroline Aquino Moreira-Nunes. (2021) Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations. Pharmaceutics 13:10, pages 1604.
Crossref

Mohammed F. Almatani, Atham Ali, Sandra Onyemaechi, Yang Zhao, Lucas Gutierrez, Vijaya Pooja Vaikari & Houda Alachkar. (2021) Strategies targeting FLT3 beyond the kinase inhibitors. Pharmacology & Therapeutics 225, pages 107844.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Quizartinib for the treatment of acute myeloid leukemia

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Quizartinib for the treatment of acute myeloid leukemia

Citations (13)

Articles from other publishers (13)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date